Article ID Journal Published Year Pages File Type
5557984 Progress in Neuro-Psychopharmacology and Biological Psychiatry 2017 7 Pages PDF
Abstract
We identified no significant predictive effect using PRS between pharmacogenetic studies. The genetic liability to MDD or schizophrenia did not predict response to antidepressants, suggesting differences between the genetic component of depression and treatment response. Larger or more homogeneous studies will be necessary to obtain a polygenic predictor of antidepressant response.
Related Topics
Life Sciences Neuroscience Biological Psychiatry
Authors
, , , , , , , , , , , , , ,